Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00439712Phase 4Completed
A Phase 4 trial of levocetirizine in perennial allergic rhinitis (PAR), sponsored by Institut für Atemwegsforschung. Started Feb 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00439712.